Andrew Carter

Managing Associate
Andrew helps domestic and international clients implement their strategic goals through M&A transactions.
Andrew helps domestic and international clients implement their strategic goals through M&A transactions.

About

Andrew is a collaborative and decisive lawyer, specialising in domestic and cross-border mergers and acquisitions. His practice spans the logistics, technology, insurance and life sciences sectors.

Andrew joined Stevens & Bolton in 2023 and previously worked at two leading international City firms where he was also seconded for six months to an investment bank. He works with large companies and institutions as well as entrepreneurs and management teams to get deals done – helping clients resolve issues commercially in an approachable manner. Andrew has a particular interest in assisting clients with their strategic international goals and is experienced in working and developing relationships with overseas law firms.

Expertise
Corporate advisory Corporate transactions Life sciences

Experience

  • Recent work
    • A FTSE 100 on multiple acquisitions in the food distribution and logistics space;
    • An international real estate fund on various transactions including a £250m sale of a logistics portfolio and a £60m sale of a retail asset;
    • A German investment fund on a £600m acquisition of an offshore corporate structure holding a premium real estate asset in the City;
    • A Japanese listed business on its £300m minority investment into a sport streaming service;
    • The sellers of an international proptech business on their complex reorganisation and c.£100m sale to a US institutional investor;
    • A US institutional investor on its £55m acquisition of a translation software business;
    • A NASDAQ listed business on its USD25m acquisition of a pan-European AI SaaS business;
    • The founders of a specialist medical liability underwriter in their minority sale to a US insurer;
    • A NYSE medical device and healthcare solutions business on English law aspects of its global restructuring;
    • A biotech company on its complex restructuring, funding rounds and commercialisation.
  • A FTSE 100 on multiple acquisitions in the food distribution and logistics space;
  • An international real estate fund on various transactions including a £250m sale of a logistics portfolio and a £60m sale of a retail asset;
  • A German investment fund on a £600m acquisition of an offshore corporate structure holding a premium real estate asset in the City;
  • A Japanese listed business on its £300m minority investment into a sport streaming service;
  • The sellers of an international proptech business on their complex reorganisation and c.£100m sale to a US institutional investor;
  • A US institutional investor on its £55m acquisition of a translation software business;
  • A NASDAQ listed business on its USD25m acquisition of a pan-European AI SaaS business;
  • The founders of a specialist medical liability underwriter in their minority sale to a US insurer;
  • A NYSE medical device and healthcare solutions business on English law aspects of its global restructuring;
  • A biotech company on its complex restructuring, funding rounds and commercialisation.
Great people - commercial, responsive and ultimately good people to work with.

Related Insights